{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:22:53Z","timestamp":1789525373606,"version":"build-2803163510"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA243910"],"award-info":[{"award-number":["R01CA243910"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA000167"],"award-info":[{"award-number":["K12DA000167"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tobacco use disorder (TUD) is a major threat to health among people with HIV (PWH), but it is often untreated. Among HIV clinicians and staff, we sought to characterize practices, attitudes, and confidence addressing TUD among PWH to identify potential opportunities to enhance provision of care. Cross-sectional deidentified, web-based surveys were administered from November 4, 2020 through December 15, 2020 in HIV clinics in three health systems in the United States Northeast. Surveys assessed provider characteristics and experience, reported practices addressing tobacco use, and knowledge and attitudes regarding medications for TUD. Chi-square tests or Fisher\u2019s exact tests were used to examine differences in responses between clinicians and staff who were prescribers versus nonprescribers and to examine factors associated with frequency of prescribing TUD medications. Among 118 survey respondents (56% prescribers), only 50% reported receiving prior training on brief smoking cessation interventions. Examining reported practices identified gaps in the delivery of TUD care, including counseling patients on the impact of smoking on HIV, knowledge of clinical practice guidelines, and implementation of assessment and brief interventions for smoking. Among prescribers, first-line medications for TUD were infrequently prescribed and concerns about medication side effects and interaction with antiretroviral treatments were associated with low frequency of prescribing. HIV clinicians and staff reported addressable gaps in their knowledge, understanding, and practices related to tobacco treatment. Additional work is needed to identify ways to ensure adequate training for providers to enhance the delivery of TUD treatment in HIV clinic settings.<\/jats:p>","DOI":"10.1093\/tbm\/ibac022","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T16:47:14Z","timestamp":1653410834000},"page":"726-733","source":"Crossref","is-referenced-by-count":10,"title":["Practices, attitudes, and confidence related to tobacco treatment interventions in HIV clinics: a multisite cross-sectional survey"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8012-6118","authenticated-orcid":false,"given":"Krysten W","family":"Bold","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine , New Haven, CT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Deng","sequence":"additional","affiliation":[{"name":"Yale Center for Analytic Sciences, Yale School of Public Health , New Haven, CT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dziura","sequence":"additional","affiliation":[{"name":"Yale Center for Analytic Sciences, Yale School of Public Health , New Haven, CT , USA"},{"name":"Department of Emergency Medicine, Yale School of Medicine , New Haven, CT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Porter","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine , New Haven, CT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M","family":"Sigel","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E","family":"Yager","sequence":"additional","affiliation":[{"name":"State University of New York Downstate Health Sciences University , Brooklyn, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Ledgerwood","sequence":"additional","affiliation":[{"name":"Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine , Detroit, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Geisel School of Medicine at Dartmouth , Lebanon, NH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Jennifer","family":"Edelman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine , New Haven, CT , USA"},{"name":"Program in Addiction Medicine, Yale School of Medicine , New Haven, CT , USA"},{"name":"Center for Interdisciplinary Research on AIDS, Yale School of Public Health , New Haven, CT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"issue":"6","key":"2022070706065955600_CIT0001","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0000000000002815","article-title":"Worldwide relative smoking prevalence among people living with and without HIV.","volume":"35","author":"Johnston","year":"2021","journal-title":"AIDS."},{"issue":"1","key":"2022070706065955600_CIT0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-021-00799-3","article-title":"Global burden of active smoking among people living with HIV on antiretroviral therapy: a systematic review and meta-analysis.","volume":"10","author":"Ale","year":"2021","journal-title":"Infect Dis Poverty."},{"key":"2022070706065955600_CIT0003","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ypmed.2018.03.007","article-title":"Trends in cigarette smoking among adults with HIV compared with the general adult population, United States\u20142009\u20132014.","volume":"111","author":"Frazier","year":"2018","journal-title":"Prev Med."},{"key":"2022070706065955600_CIT0004","first-page":"17","volume-title":"The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General","author":"USDHHS.","year":"2014"},{"issue":"12","key":"2022070706065955600_CIT0005","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/ntr\/ntw126","article-title":"Smoking cessation for people living with HIV\/AIDS: a literature review and synthesis.","volume":"18","author":"Ledgerwood","year":"2016","journal-title":"Nicotine Tob Res."},{"issue":"5","key":"2022070706065955600_CIT0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/cis933","article-title":"Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study.","volume":"56","author":"Helleberg","year":"2013","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2022070706065955600_CIT0007","doi-asserted-by":"crossref","first-page":"e8896","DOI":"10.1371\/journal.pone.0008896","article-title":"Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000\u20132007.","volume":"5","author":"Benard","year":"2010","journal-title":"PLoS One."},{"issue":"7","key":"2022070706065955600_CIT0008","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1468-1293.2010.00901.x","article-title":"Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).","volume":"12","author":"Petoumenos","year":"2011","journal-title":"HIV Med."},{"issue":"9","key":"2022070706065955600_CIT0009","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/apc.2007.0022","article-title":"The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV\/AIDS.","volume":"21","author":"Vidrine","year":"2007","journal-title":"AIDS Patient Care STDS."},{"issue":"11","key":"2022070706065955600_CIT0010","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jamainternmed.2017.4349","article-title":"Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States.","volume":"177","author":"Reddy","year":"2017","journal-title":"JAMA Intern Med."},{"key":"2022070706065955600_CIT0011","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugalcdep.2019.03.011","article-title":"Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV.","volume":"200","author":"Ashare","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"2022070706065955600_CIT0012","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/S2352-3018(18)30002-X","article-title":"Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.","volume":"5","author":"Merci\u00e9","year":"2018","journal-title":"Lancet HIV."},{"issue":"5","key":"2022070706065955600_CIT0013","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QAI.0000000000001007","article-title":"Behavioral interventions for tobacco use in HIV-infected smokers: a meta-analysis.","volume":"72","author":"Keith","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"11","key":"2022070706065955600_CIT0014","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/j.1360-0443.2009.02623.x","article-title":"Motivation and patch treatment for HIV+ smokers: a randomized controlled trial.","volume":"104","author":"Lloyd-Richardson","year":"2009","journal-title":"Addiction."},{"key":"2022070706065955600_CIT0015","author":"Department of Health and Human Services."},{"key":"2022070706065955600_CIT0016","volume-title":"Integrating tobacco control into tuberculosis and HIV responses: implementing the WHO Framework Convention on Tobacco Control to address co-morbidities","author":"WHO Framework Convention on Tobacco Control.","year":"2018"},{"issue":"1","key":"2022070706065955600_CIT0017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/108729102753429389","article-title":"Cigarette smoking and the desire to quit among individuals living with HIV.","volume":"16","author":"Mamary","year":"2002","journal-title":"AIDS Patient Care STDS."},{"issue":"1","key":"2022070706065955600_CIT0018","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5993\/AJHB.36.1.8","article-title":"Cigarette smoking behaviors and beliefs in persons living with HIV\/AIDS.","volume":"36","author":"Shuter","year":"2012","journal-title":"Am J Health Behav."},{"issue":"7","key":"2022070706065955600_CIT0019","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/apc.2006.0142","article-title":"Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort.","volume":"21","author":"Benard","year":"2007","journal-title":"AIDS Patient Care STDS."},{"issue":"4","key":"2022070706065955600_CIT0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11904-015-0281-9","article-title":"Tobacco use, use disorders, and smoking cessation interventions in persons living with HIV.","volume":"12","author":"Pacek","year":"2015","journal-title":"Curr HIV\/AIDS Rep."},{"issue":"7","key":"2022070706065955600_CIT0021","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/10826084.2020.1726395","article-title":"Smokers\u2019 receipt of cessation advice from healthcare professionals in national samples of people diagnosed with HIV and the general population.","volume":"55","author":"Timberlake","year":"2020","journal-title":"Subst Use Misuse."},{"issue":"4","key":"2022070706065955600_CIT0022","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/09540121.2018.1500007","article-title":"Addressing smoking among people living with HIV: a cross-sectional survey of Australian HIV health practitioners\u2019 practices and attitudes.","volume":"31","author":"Bell","year":"2019","journal-title":"AIDS Care."},{"key":"2022070706065955600_CIT0023","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pmedr.2017.02.012","article-title":"Disparities in receipt of 5As for smoking cessation in diverse primary care and HIV clinics.","volume":"6","author":"Vijayaraghavan","year":"2017","journal-title":"Prev Med Rep."},{"issue":"2","key":"2022070706065955600_CIT0024","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pcad.2020.01.003","article-title":"Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV.","volume":"63","author":"Shahrir","year":"2020","journal-title":"Prog Cardiovasc Dis."},{"key":"2022070706065955600_CIT0025","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study.","volume":"56","author":"Altice","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"key":"2022070706065955600_CIT0026","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/QAI.0b013e3182097537","article-title":"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine\/naloxone.","volume":"56","author":"Fiellin","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"key":"2022070706065955600_CIT0027","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/QAI.0b013e31820bc9a5","article-title":"Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.","volume":"56","author":"Korthuis","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"key":"2022070706065955600_CIT0028","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/QAI.0b013e31820a8226","article-title":"Integration of buprenorphine\/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.","volume":"56","author":"Weiss","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"key":"2022070706065955600_CIT0029","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10461-018-2241-z","article-title":"Efficacy of extended-release naltrexone on HIV-related and drinking outcomes among HIV-positive patients: a randomized-controlled trial.","volume":"23","author":"Edelman","year":"2019","journal-title":"AIDS Behav."},{"issue":"6","key":"2022070706065955600_CIT0030","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/add.13753","article-title":"Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot\/feasibility randomized trial.","volume":"112","author":"Korthuis","year":"2017","journal-title":"Addiction."},{"key":"2022070706065955600_CIT0031","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cct.2016.11.008","article-title":"The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients.","volume":"52","author":"Edelman","year":"2017","journal-title":"Contemp Clin Trials."},{"issue":"1","key":"2022070706065955600_CIT0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-015-0048-z","article-title":"Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics.","volume":"11","author":"Edelman","year":"2016","journal-title":"Addict Sci Clin Pract."},{"key":"2022070706065955600_CIT0033","doi-asserted-by":"crossref","first-page":"106379","DOI":"10.1016\/j.cct.2021.106379","article-title":"A SMART approach to treating tobacco use disorder in persons with HIV (SMARTTT): rationale and design for a hybrid type 1 effectiveness-implementation study.","volume":"110","author":"Edelman","year":"2021","journal-title":"Contemp Clin Trials."},{"issue":"3","key":"2022070706065955600_CIT0034","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care."},{"issue":"3","key":"2022070706065955600_CIT0035","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/QAI.0000000000002666","article-title":"Readiness to provide medications for opioid, alcohol and tobacco use disorder in HIV clinics: a multi-site mixed-methods formative evaluation.","volume":"87","author":"Edelman","year":"2021","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"8","key":"2022070706065955600_CIT0036","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/QAD.0b013e328352d1ad","article-title":"HIV as an independent risk factor for incident lung cancer.","volume":"26","author":"Sigel","year":"2012","journal-title":"AIDS."},{"issue":"7","key":"2022070706065955600_CIT0037","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/QAD.0000000000000189","article-title":"Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening.","volume":"28","author":"Sigel","year":"2014","journal-title":"AIDS."},{"issue":"5","key":"2022070706065955600_CIT0038","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/DCR.0000000000001307","article-title":"Anal cancer precursor lesions in HIV-infected persons: tissue human papillomavirus type distribution and impact on treatment response.","volume":"62","author":"Kobayashi","year":"2019","journal-title":"Dis Colon Rectum."},{"key":"2022070706065955600_CIT0039","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform."},{"issue":"2","key":"2022070706065955600_CIT0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"key":"2022070706065955600_CIT0041","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1097\/QAI.0b013e31820a9a82","article-title":"Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings.","volume":"56","author":"Lum","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"5","key":"2022070706065955600_CIT0042","doi-asserted-by":"crossref","first-page":"e204561","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine.","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Netw Open."},{"issue":"3","key":"2022070706065955600_CIT0043","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugalcdep.2011.08.027","article-title":"Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire.","volume":"121","author":"Rash","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"2022070706065955600_CIT0044","volume-title":"Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline","author":"Fiore","year":"2008"},{"issue":"2","key":"2022070706065955600_CIT0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ntr\/ntaa155","article-title":"The United States National Cancer Institute\u2019s coordinated research effort on tobacco use as a major cause of morbidity and mortality among people with HIV.","volume":"23","author":"Ashare","year":"2021","journal-title":"Nicotine Tob Res."},{"issue":"1","key":"2022070706065955600_CIT0046","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAI.0000000000001636","article-title":"Associations between multiple forms of discrimination and tobacco use among people living with HIV: the mediating role of avoidance coping.","volume":"78","author":"Crockett","year":"2018","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"8","key":"2022070706065955600_CIT0047","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.2105\/AJPH.2012.301112","article-title":"Undertreatment of tobacco use relative to other chronic conditions.","volume":"103","author":"Bernstein","year":"2013","journal-title":"Am J Public Health."}],"container-title":["Translational Behavioral Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/tbm\/article-pdf\/12\/6\/726\/44519765\/ibac022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/tbm\/article-pdf\/12\/6\/726\/44519765\/ibac022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T06:08:52Z","timestamp":1657174132000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/tbm\/article\/12\/6\/726\/6591319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,5,24]]},"published-print":{"date-parts":[[2022,7,7]]}},"URL":"https:\/\/doi.org\/10.1093\/tbm\/ibac022","relation":{},"ISSN":["1869-6716","1613-9860"],"issn-type":[{"value":"1869-6716","type":"print"},{"value":"1613-9860","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,5,24]]}}}